Skip to content

A Comparative Study to see the effect of Kokilaksha Tablet & Guduchi Tablet in the management of Gout

A Randomised Comparative Clinical Study to evaluate the efficacy of Kokilaksha Ghanavati & Guduchi Ghanavati in the management of Vatarakta(Gout)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050927
Enrollment
60
Registered
2023-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M10- Gout

Interventions

None listed

Sponsors

Dr Aarti Devkisan Gaikar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age limit from 18 to 70 years. Patients having clinical symptoms of Vatarakta like joint pain, joint swelling, burning sensation, tenderness at joints, stiffness, local color changes in the skin. Sr uric acid level â?? 2.5 â?? 12 mg/dl.

Exclusion criteria

Exclusion criteria: 1) Patient with severe form of other systemic disorders like Cardiac disease, Renal failure, CVA etc. 2) Pregnant women and lactating mothers. 3) Injury requiring surgical interventions. 4) Any condition interfering the course of treatment. 5) Secondary hyperuricemia due to leukaemia, lymphoma, polycythaemia.

Design outcomes

Primary

MeasureTime frame
Reduction in Pain.Timepoint: Baseline- 0 day,7 day,14 day.

Secondary

MeasureTime frame
To observe the adverse effect, if any.Timepoint: 14 days study with follow up on 7th and 14th day.(0,7,14)

Countries

India

Contacts

Public ContactDr Aarti Devkisan Gaikar

Dr. D.Y.Patil College of Ayurved Hospital and Research Centre

vjayu82@gmail.com8983478062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026